If you are struggling with mental health issues, Vraylar may be a medication that may help improve your symptoms and overall well-being. This article will discuss the uses, benefits, side effects, and warnings of Vraylar.
Uses
Vraylar is an atypical antipsychotic medication that is prescribed to treat several mental health conditions, including:
- Schizophrenia
- Bipolar disorder (manic or mixed episodes)
- Depressive episodes associated with bipolar I disorder
Vraylar may help relieve symptoms such as hallucinations, delusions, and disordered thinking in individuals with schizophrenia. It may also help stabilize mood and prevent or reduce episodes of mania or depression in individuals with bipolar disorder.
Benefits
When prescribed and used correctly, Vraylar may offer several benefits to individuals struggling with mental health conditions. These benefits include:
- Improved Mood: Vraylar may help stabilize mood and prevent or reduce episodes of mania or depression in individuals with bipolar disorder.
- Reduced Psychotic Symptoms: Vraylar may help alleviate symptoms such as hallucinations, delusions, and disordered thinking in individuals with schizophrenia.
- Better Quality of Life: By relieving symptoms and stabilizing mood, Vraylar may help individuals struggling with mental health issues feel better overall, leading to an improved quality of life.
Side Effects
As with any medication, there is a risk of side effects when using Vraylar. Some of the most common side effects associated with Vraylar include:
- Restlessness
- Nausea
- Vomiting
- Dizziness
- Drowsiness
- Weight gain
Other, less common but more severe side effects may also occur. These may include:
- Involuntary movements (tardive dyskinesia)
- Increased risk of stroke or transient ischemic attack (TIA)
- Low white blood cell count (agranulocytosis)
- High blood sugar (hyperglycemia)
If you experience any of these side effects, it is important to reach out to your healthcare provider immediately.
Warnings
There are several important warnings that individuals taking Vraylar should be aware of. These warnings include:
- Increased Risk of Death: Elderly individuals with dementia-related psychosis who are treated with antipsychotic drugs like Vraylar may have an increased risk of death.
- Neuroleptic Malignant Syndrome (NMS): Rare but potentially fatal condition associated with antipsychotic medications. Symptoms may include high fever, muscle rigidity, and confusion.
- Tardive Dyskinesia (TD): Some individuals taking Vraylar may develop involuntary movements of the tongue, lips, face, or limbs. TD is a serious condition that may be irreversible, so it is important to report any symptoms to your healthcare provider immediately.
- Antidepressant Use: Individuals taking Vraylar for bipolar disorder should also inform their healthcare provider if they are taking antidepressants. Combining Vraylar with certain antidepressants may increase the risk of serotonin syndrome.
FAQs
The length of time it takes for Vraylar to start working can vary depending on the individual and their condition. It may take several weeks or more for individuals with bipolar disorder to notice a reduction in symptoms, and several months for individuals with schizophrenia to notice improvement.
Vraylar can be taken with or without food. However, if you experience nausea and vomiting while taking Vraylar, taking it with food may help reduce these side effects.
It is not recommended to drink alcohol while taking Vraylar, as it may increase the risk of side effects such as dizziness and drowsiness.
There is limited information on the safety of Vraylar during pregnancy. Therefore, it is important to discuss the benefits and risks of using Vraylar during pregnancy with your healthcare provider.
It is important to inform your healthcare provider of any other medications you are taking, as some medications may interact with Vraylar and increase the risk of side effects. Additionally, Vraylar may interact with certain antidepressants in individuals with bipolar disorder, which may increase the risk of serotonin syndrome.
